{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:08:35Z","timestamp":1793214515099,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To report a case of Pediatric-onset MS associated uveitis managed with local and systemic medications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>An 11-year-old boy who was diagnosed with Pediatric-onset MS (POMS) with the first presentation of left optic neuritis in another center, was referred to our clinic with the complaint of non-improved vision in the left eye despite receiving IV 5gr methylprednisolone. After the ophthalmologic examinations, the patient was diagnosed as bilateral POMS-associated intermediate uveitis, and local treatment with corticosteroid was administered to both eyes. He was continued on systemic therapy such as Rituximab and five sessions of plasmapheresis. After four months, the patient's vision improved from FC at 50cm to 9\/10 in the left eye. The intensity of intraocular inflammation decreased in both eyes. In fluorescein angiography findings, the optic disc, as well as vascular leakage, subsided bilaterally.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Despite its rarity, POMS-associated uveitis presents a considerable challenge that necessitates the collaborative efforts of neurologists and ophthalmologists to achieve the most effective treatment outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12348-024-00405-1","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T17:02:04Z","timestamp":1717002124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A case report of pediatric-onset MS associated uveitis"],"prefix":"10.1186","volume":"14","author":[{"given":"Zahra","family":"Mahdizad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Fakhredin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Samiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hora","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Ebrahimiadib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,29]]},"reference":[{"issue":"3","key":"405_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509\u201316","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"405_CR2","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.ophtha.2005.01.044","volume":"112","author":"LI Kump","year":"2005","unstructured":"Kump LI et al (2005) Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology 112(7):1287\u20131292","journal-title":"Ophthalmology"},{"issue":"3","key":"405_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1080\/09273948.2017.1420202","volume":"27","author":"M Ferrara","year":"2019","unstructured":"Ferrara M et al (2019) The challenge of pediatric uveitis: tertiary referral center experience in the United States. Ocul Immunol Inflamm 27(3):410\u2013417","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"405_CR4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/1120672120904667","volume":"31","author":"AF AlBloushi","year":"2021","unstructured":"AlBloushi AF et al (2021) Clinical findings and outcomes of uveitis associated with multiple sclerosis. Eur J Ophthalmol 31(2):482\u2013490","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"405_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/biomedicines8040071","volume":"8","author":"KS Fisher","year":"2020","unstructured":"Fisher KS et al (2020) Current advances in pediatric onset multiple sclerosis. Biomedicines 8(4):71","journal-title":"Biomedicines"},{"issue":"10","key":"405_CR6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1055\/s-0032-1315045","volume":"229","author":"M Pfriem","year":"2012","unstructured":"Pfriem M, Ababneh L, Schittkowski MP (2012) Ophthalmological findings in paediatric and adolescent multiple sclerosis. Klin Monbl Augenheilkd 229(10):1021\u20131023","journal-title":"Klin Monbl Augenheilkd"},{"issue":"1","key":"405_CR7","doi-asserted-by":"publisher","first-page":"13473","DOI":"10.1038\/s41598-022-17701-2","volume":"12","author":"N Ebrahimiadib","year":"2022","unstructured":"Ebrahimiadib N et al (2022) Non-cystic macular thickening on optical coherence tomography as an alternative to fluorescein angiography for predicting retinal vascular leakage in early stages of uveitis. Sci Rep 12(1):13473","journal-title":"Sci Rep"},{"issue":"7","key":"405_CR8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.59.7.1006","volume":"59","author":"A Boiko","year":"2002","unstructured":"Boiko A et al (2002) Early onset multiple sclerosis: a longitudinal study. Neurology 59(7):1006\u20131010","journal-title":"Neurology"},{"key":"405_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-018-1026-3","volume":"18","author":"R Alroughani","year":"2018","unstructured":"Alroughani R, Boyko A (2018) Pediatric multiple sclerosis: a review. BMC Neurol 18:1\u20138","journal-title":"BMC Neurol"},{"issue":"10","key":"405_CR10","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/1352458513484547","volume":"19","author":"LB Krupp","year":"2013","unstructured":"Krupp LB et al (2013) International pediatric multiple sclerosis study group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 19(10):1261\u20131267","journal-title":"Mult Scler"},{"key":"405_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajo.2021.03.044","volume":"228","author":"Standardization of Uveitis Nomenclature (SUN) Working Group","year":"2021","unstructured":"Standardization of Uveitis Nomenclature (SUN) Working Group (2021) Classification criteria for multiple sclerosis-associated intermediate uveitis. Am J Ophthalmol 228:72\u201379","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"405_CR12","doi-asserted-by":"publisher","first-page":"e909","DOI":"10.1212\/NXI.0000000000000909","volume":"8","author":"A Abraham","year":"2020","unstructured":"Abraham A et al (2020) Intermediate uveitis associated with MS: diagnosis, clinical features, pathogenic mechanisms, and recommendations for management. Neurol Neuroimmunol Neuroinflamm 8(1):e909","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"405_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.msard.2019.07.004","volume":"35","author":"M Manguinao","year":"2019","unstructured":"Manguinao M et al (2019) A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children. Multiple Sclerosis Relat Disord 35:50\u201354","journal-title":"Multiple Sclerosis Relat Disord"},{"issue":"11","key":"405_CR14","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1177\/0883073812452785","volume":"27","author":"EA Yeh","year":"2012","unstructured":"Yeh EA, Weinstock-Guttman B (2012) The management of pediatric multiple sclerosis. J Child Neurol 27(11):1384\u20131393","journal-title":"J Child Neurol"},{"issue":"9 Supplement 2","key":"405_CR15","first-page":"S110","volume":"87","author":"E Wassmer","year":"2016","unstructured":"Wassmer E et al (2016) International pediatric MS study group global members symposium report. Neurology 87(9 Supplement 2):S110\u2013S116","journal-title":"Neurology"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-024-00405-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-024-00405-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-024-00405-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T17:04:09Z","timestamp":1717002249000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-024-00405-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,29]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1186\/s12348-024-00405-1","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,29]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of the patient\u2019s details and clinical images was obtained from the parent of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}